Seroprevalence of Anti-SARS-Cov-2 IgG Antibodies In Tertiary Care Hospital, Chandrapur
No Thumbnail Available
Date
2025-07
Journal Title
Journal ISSN
Volume Title
Publisher
Indian Society for Health and Advanced Research
Abstract
Background: Many studies examined the spread of SARS-CoV-2 within populations using seroprevalence. The aim of this study was to estimate the seroprevalence of SARS-CoV-2 speci?c IgG antibodies from May 2020 to December 2023 in Chandrapur, Maharashtra. The data was collected between May 2020Methods: to Dec 2023. In this study, we conducted an immunologic study to determine the seroprevalence of anti-SARS-CoV-2 antibodies in hospitals. Blood samples were collected randomly from 390924 individuals who were SARS CoV-2 RT-PCR negative across Chandrapur, Maharashtra. The serum samples were tested for SARS-CoV-2 IgG antibodies using Enzyme linked Immunosorbent Assay (ELISA) method. 14.32% of samples had anti-SARS-CoV 2 IgG antibodies, with a slightly higherResults: incidence in males than in females. Additionally, people in the 21-40 age range and those living in cities showed higher levels of positivity. The signi?cance of anti-SARS-CoV-2 IgG antibody serosurveillance among RT-PCR negative persons isConclusions: suggested by this study. This will assist in halting the spread of infection and developing infection prevention procedures.
Description
Keywords
COVID-19, IgG antibodies, SARS-CoV-2, serosurvey
Citation
Komatwar Neha, Kolhe Virendra, Tore Rajani, Surpam Rajendra. Seroprevalence of Anti-SARS-Cov-2 IgG Antibodies In Tertiary Care Hospital, Chandrapur. Global Journal For Research Analysis (GJRA). 2025 Jul; 14(7): 1-2